Catalyst Wire Dossier Catalyst Wire Dossier

Ad5FGF-4

adenovirus type 5 fibroblast growth factor-4 gene therapy · Cardium Therapeutics
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Ad5FGF-4, covering 2008-11-06 to 2022-07-19. Get the full timeline:

Most recent: Clinical Trial Update: Ad5FGF-4 In Patients With Refractory Angina Due to Myocardial Ischemia [Phase 3]

See pricing